Enhanced Tumor Delivery of Gemcitabine via PEG-DSPE/TPGS Mixed Micelles

[Image: see text] Gemcitabine is a potent anticancer drug approved for the treatment of pancreatic, non-small-cell lung, breast, and ovarian cancers. The major deficiencies of current gemcitabine therapy, however, are its rapid metabolic inactivation and narrow therapeutic window. Herein, we employe...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yingzhe, Fan, Wei, Dai, Xin, Katragadda, Usha, Mckinley, DeAngelo, Teng, Quincy, Tan, Chalet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3993932/
https://www.ncbi.nlm.nih.gov/pubmed/24579673
http://dx.doi.org/10.1021/mp4005904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3993932/
https://www.ncbi.nlm.nih.gov/pubmed/24579673
http://dx.doi.org/10.1021/mp4005904

Ejemplares similares